Valuation: Pharmicell Co., Ltd.

Capitalization 173B 117M 101M 94.55M 88.13M 163M 10.57B 177M 1.11B 427M 4.99B 441M 431M 18.25B P/E ratio 2012
-10.9x
P/E ratio 2013 -6.22x
Enterprise value 179B 122M 105M 98.01M 91.35M 169M 10.95B 184M 1.15B 443M 5.17B 457M 447M 18.92B EV / Sales 2012
19.8x
EV / Sales 2013 5.1x
Free-Float
90.27%
Yield 2012 *
-
Yield 2013 -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.76%
1 week+2.08%
Current month+0.47%
1 month-6.01%
3 months+60.65%
6 months+43.73%
Current year+107.61%
More quotes
1 week 16,170
Extreme 16170
17,500
1 month 15,690
Extreme 15690
20,800
Current year 7,150
Extreme 7150
20,800
1 year 4,520
Extreme 4520
20,800
3 years 4,300
Extreme 4300
20,800
5 years 4,300
Extreme 4300
22,050
10 years 3,590
Extreme 3590
26,350
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 2009-08-18
Corporate Officer/Principal 54 2013-03-31
Corporate Officer/Principal 49 2009-08-18
Director TitleAgeSince
Chairman 61 2009-08-18
Director/Board Member 61 2011-08-11
Director/Board Member 70 2020-03-24
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.76%+2.08%+281.15%+70.20% 695M
-0.59%-7.69%-6.22%-4.67% 74.16B
-0.81%-1.12%-34.98%-39.02% 59.32B
+3.17%+3.77%+31.61%+234.28% 53.15B
-2.32%+64.10%+64.10%+64.10% 52.8B
-0.18%+0.03%+14.37%-37.78% 26.7B
-1.66%-4.37%+145.01%+231.53% 20.6B
+2.00%-1.91%+36.76%+21.86% 19.72B
-12.04%-12.38%+43.55%+1,140.49% 18.85B
-1.40%+2.20%+176.05%+702.56% 14.41B
Average -1.31%-2.18%+75.14%+238.35% 34.04B
Weighted average by Cap. -0.85%-2.89%+29.90%+144.05%
See all sector performances

Financials

2012 2013
Net sales 11.11B 7.54M 6.49M 6.08M 5.66M 10.46M 679M 11.38M 71.06M 27.44M 321M 28.31M 27.71M 1.17B 33.41B 22.68M 19.5M 18.26M 17.02M 31.44M 2.04B 34.2M 214M 82.48M 964M 85.12M 83.31M 3.52B
Net income -17.64B -11.98M -10.3M -9.65M -8.99M -16.61M -1.08B -18.06M -113M -43.56M -509M -44.96M -44M -1.86B -25.7B -17.45M -15M -14.05M -13.1M -24.19M -1.57B -26.31M -164M -63.46M -742M -65.49M -64.09M -2.71B
Net Debt 6.08B 4.13M 3.55M 3.32M 3.1M 5.72M 371M 6.22M 38.87M 15.01M 175M 15.49M 15.16M 641M 6.33B 4.3M 3.69M 3.46M 3.23M 5.96M 387M 6.48M 40.48M 15.63M 183M 16.13M 15.78M 668M
More financial data * Estimated data
Logo Pharmicell Co., Ltd.
Pharmicell Co., Ltd. is a Korea-based company principally engaged in the biopharmaceutical business. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. It also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides women’s and men’s apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.
Employees
-
More about the company
Date Price Change Volume
25-12-04 17,190.00 +0.76% 1,267,010
25-12-04 17,060.00 -1.10% 1,613,317
25-12-03 17,250.00 +4.80% 2,995,892
25-12-02 16,460.00 +0.98% 1,257,388
25-12-01 16,300.00 -4.73% 2,175,259

End-of-day quote Korea S.E., December 04, 2025

More quotes
  1. Stock Market
  2. Equities
  3. A005690 Stock